Sign In
Buy BAYRY
$13.89
-0.110 (-0.786%)
At Close: Jul 31, 2026
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced the submission of a supplemental new drug application (sNDA) to the U.S. Food and Drug Administration (FDA) for KERENDIA® (finerenone) for the t
Orion's collaboration partner Bayer submits application in China for third indication of darolutamide
02:00am, Tuesday, 07'th Jan 2025
ORION CORPORATION INVESTOR NEWS 7 JANUARY 2025 at 9:00 EET Orion's collaboration partner Bayer submits application in China for third indication of darolutamide Orion's collaboration
Bayer: Federal Court Brings an End to Roundup™ Litigation in Australia
08:54am, Friday, 03'rd Jan 2025
LEVERKUSEN, Germany--(BUSINESS WIRE)--The Federal Court of Australia brought an end to the last Roundup™ case in Australia, closing all pending injury litigation there. The Court granted the plainti
Bayer Partners with America's Grow-A-Row to Aid in the Fight Against Hunger in New Jersey
08:10am, Tuesday, 17'th Dec 2024
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer announced the successful completion of its fall employee engagement campaign with America's Grow-a-Row (AGAR), a New Jersey-based, nonprofit farm where approxima
Bayer's Stock Hits 2-Decade Low: Why It Is A Buy Again
03:08am, Friday, 06'th Dec 2024
Bayer's stock has declined below €20, with Q3/24 results showing a 3.6% sales decrease and a 29.8% EBITDA drop, mainly due to currency effects. Crop Science sales fell 9.1% YoY, and Pharmaceuticals
Bayer Showcases Growing Radiology Portfolio at RSNA 2024
10:10am, Sunday, 01'st Dec 2024
CHICAGO--(BUSINESS WIRE)--Bayer continues to advance its comprehensive Radiology portfolio with progress in the development pipeline as well as innovations around Artificial Intelligence (AI) and will
Dublin, Nov. 29, 2024 (GLOBE NEWSWIRE) -- The "Watermelon Seeds Market Size, Share & Trends Analysis Report by Type (Raw, Roasted, Dried), Distribution Channel, Region and Segment Forecasts, 2025-2030
FDA Accepts Bayer's Application for Label Expansion of Nubeqa
02:41pm, Friday, 22'nd Nov 2024
Bayer's efforts to expand Nubeqa's label in prostate cancer make progress with the FDA's acceptance of the company's sNDA.
Bayer Announces ‘Project Enhanced S3' to Enable Companies to Realize Additional Sustainability Value from Carbon Removal Projects
09:00am, Thursday, 21'st Nov 2024
ST. LOUIS--(BUSINESS WIRE)--Bayer announced today an expanded approach to its programs that sequester carbon and reduce emissions for companies along the food value chain through regenerative agricult
Bayer Acquires Rights for Cardiovascular Drug From CYTK in Japan
10:31am, Wednesday, 20'th Nov 2024
BAYRY enters into a collaboration and license agreement with Cytokinetics for the exclusive development and commercialization of aficamten in Japan.
Bayer acquires rights to Cytokinetics' heart drug in Japan
03:26am, Tuesday, 19'th Nov 2024
Bayer on Tuesday struck a collaboration deal with U.S. biotech firm Cytokinetics to acquire certain rights in Japan to an experimental heart drug, as the German group strengthens its cardiovascular bu
Bayer shareholders call on CEO to stem the tide of bad news
01:03am, Friday, 15'th Nov 2024
Some Bayer investors say CEO Bill Anderson should speed up turnaround efforts, including boosting efficiency and drug development, to restore confidence and revive the company's share price that hit 2
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer will present three new prespecified subgroup analyses from the pivotal Phase III FINEARTS-HF cardiovascular outcomes trial investigating KERENDIA® (finerenone)
Bayer Q3 Earnings Miss Estimates, Nubeqa, Kerendia Boost Sales
02:40pm, Tuesday, 12'th Nov 2024
BAYRY's third-quarter earnings get affected due to impairment losses at the Crop Science division. Sales gain from the Pharmaceutical business's strong performance.
Bayer AG (BAYZF) Q3 2024 Earnings Call Transcript
02:14pm, Tuesday, 12'th Nov 2024
Bayer AG (OTCPK:BAYZF) Q3 2024 Earnings Conference Call November 12, 2024 8:00 AM ET Company Participants Bill Anderson - Chairman & CEO Wolfgang Nickl - CFO Julio Triana - President, Consumer Health
